Glow by Elena Reitman MD
Glow by Elena Reitman MD · 15 Broadway · Cresskill, NJ 07626
4.9· 55 Google reviews
Listing updated October 2, 2026
No current plans confirmed — RetaMaps has not yet confirmed this practice's intentions regarding retatrutide. Inclusion on RetaMaps does not mean the provider offers or will offer retatrutide.
Care described on the practice's website
- Medically supervised weight loss
About this practice
Glow by Elena Reitman MD is a physician-led medical spa in Cresskill, New Jersey. Its website describes Botox, fillers, lasers and skin rejuvenation provided by Elena Reitman, MD, a board-certified physician who it says spent years working in anesthesiology and obstetrics and gynecology at a large academic hospital before founding the practice. The listing also includes weight-loss care. On Google it holds a 4.9-star rating across 55 reviews dating back to 2022, with 10 posted in the past year. Reviewers most often mention the providers' knowledge, in 23 reviews, followed by results, the staff and a caring approach.
Services & access
| Advertises semaglutide today | Not listed |
| Advertises tirzepatide today | Not listed |
| Telehealth visits | Not listed |
| Cash pay accepted | — |
| Accepts insurance — per practice website | Yes |
| Accepting new patients — per practice website | Yes |
"Not listed" means we didn't find this stated on the practice's public pages — it doesn't mean no. — means unknown. Medication rows describe currently FDA-approved GLP-1 medications the practice advertises today, not retatrutide. Confirm details directly with the practice.
Review activity
Counts computed by RetaMaps from public Google reviews; most recent review 2026-06-26. Read the reviews themselves on the practice's Google listing.
What patients say
Rated ★4.9 across 55 Google reviews. Of the 55 reviews we analyzed, 53 (96%) are positive (4–5★) and 2 (4%) are negative (1–2★).
What patients like
- Knowledgeable, professional providers23 reviews
- Weight-loss results13 reviews
- Friendly, helpful staff11 reviews
- Feeling listened to11 reviews
Common complaints
Very few complaints — only 2 negative reviews, with no recurring theme.
Most recent Google reviews
cole★★★★★2026-06-26Dr. Reitman is as smart and capable as she is lovely! Melanie at the front is also wonderful!
Sydnie M.★★★★★2026-06-02My favorite place ever!!! They do such an amazing job making everything painless and perfect. I highly recommend!
Arlene F.★★★★★2026-05-13Dr. Reitman is nothing short of amazing. She’s incredibly skilled, totally honest, and just an all-around awesome person! Every Botox appointment with her is a breeze, she listens, she’s real with you, and she never overdoes it. The best part? I constantly get compliments on how young I look… and no one knows my secret but her!’ Forever grateful for Dr. Reitman! Love her!!
Arlene M.★★★★★2026-05-06I have been coming to Dr Elena for years. I may not be getting younger but I’m not looking older.
Gaukhar K.★★★★★2026-04-29Absolutely loved my experience at Glow by Elena! She is so professional, gentle, and really knows what she’s doing. My skin looks amazing—highly recommend!
Analysis by RetaMaps of reviews on this practice's public Google Business listing; review themes are detected automatically and reviews reflect their authors' opinions. See all reviews on Google.
Clinicians
- Glow by Elena Reitman MD
Retatrutide is Eli Lilly's investigational once-weekly triple agonist (GIP, GLP-1 and glucagon receptors). Five Phase 3 trials have reported positive results, and Lilly plans to submit it to the FDA in Q1 2027. It is not FDA-approved, has no brand name or price, and cannot be prescribed outside clinical trials or Lilly's physician-requested expanded access program. Products sold online as "research" or compounded retatrutide are not legitimate retatrutide.
- Development
- Phase 3 complete
- FDA status
- Submission planned — Q1 2027 (Lilly guidance)
- Availability
- Not commercially available
- Access routes
- Clinical trials, or Lilly's expanded access program (physician must apply)
Next milestone: TRIUMPH-5 head-to-head vs tirzepatide results (Expected ~Dec 2026)
Sources: Lilly — What to know about retatrutide · Lilly — TRIUMPH-2/TRIUMPH-3 results · BioPharma Dive — FDA submission plans · STAT — Lilly expanded access (Aug 3, 2026) · FDA — Concerns with unapproved GLP-1 drugs